S-23 Liquid vs. Capsules for Sale in the UK: Which Form Factor Wins for Laboratory Research in London, Manchester, Birmingham, Glasgow & Leeds?

For researchers seeking to order pure s-23 powder UK next day delivery, the choice between liquid and capsule formulations is more than a matter of preference. S-23 is widely regarded as the most potent and suppressive SARM available for research purposes, originally developed as a potential male hormonal contraceptive and later studied for its pronounced anabolic effects on androgen-dependent tissues . This guide provides a technical comparison of S-23 liquid and capsule formats, examining storage stability, dosing precision, and handling protocols to inform commercial buying decisions across the UK’s major research hubs.

Understanding S-23: Specifications and Research Profile

S-23 (CAS 1010396-29-8) is a non-steroidal selective androgen receptor modulator with a Ki of 1.7 nM, demonstrating high affinity for the androgen receptor . In castrated rat models, S-23 dose-dependently increases prostate, seminal vesicle, and levator ani muscle weights, with ED50 values of 0.43 mg/d and 0.079 mg/d respectively .

Key Product Specifications

PropertySpecification
CAS Number1010396-29-8
Molecular FormulaC₁₈H₁₃ClF₄N₂O₃
Molecular Weight416.75 g/mol
Purity Standard≥98% – ≥99.93% (HPLC-verified)
Physical FormWhite to off-white solid powder
Storage (Powder)-20°C (3 years); 4°C (2 years)
Storage (Solution)-80°C (2 years); -20°C (1 year)
Shipping TemperatureRoom temperature in continental US; varies elsewhere

Liquid vs. Capsule: Comparative Analysis

Capsule/Tablet Formulations

Capsules offer pre-measured dosing convenience, typically available in 10mg or 15mg concentrations. UK suppliers like Peak Body Nutrition offer S-23 in 10mg tablets, with third-party testing confirming purity levels exceeding 98%.

Advantages:

  • Pre-measured dosing eliminates handling errors
  • No reconstitution required; ready for immediate use
  • Stable at room temperature when stored dry and protected from light 

Challenges:

  • Limited flexibility for protocol adjustments
  • Excipients and fillers may affect solubility in certain research applications
  • Storage of bulk quantities requires desiccated, light-protected conditions

Liquid Formulations

Liquid S-23 is typically supplied in PEG400 or advanced carrier blends at concentrations such as 30mg/ml or 50mg/ml . UK SARMs (a competing supplier) manufactures liquid SARMs, offering free next-day UK shipping regardless of order size .

Advantages:

  • Flexible dosing allows precise volume measurement
  • Fewer excipients; primarily active compound in carrier solvent
  • Suitable for protocols requiring dose titration

Challenges:

  • Requires accurate pipetting equipment
  • Reduced stability once in solution (6 months at -20°C) 
  • May cause solvent-related effects in some research models

Storage Stability: What the Research Shows

Peer-reviewed research on SARM stability indicates that these compounds are stable in reference solutions when stored at -20°C, though certain analogs may require lower temperatures. For S-23 specifically:

  • Powder form: Stable for 3 years at -20°C, 2 years at 4°C 
  • In solution: Stable for 1 year at -20°C; 2 years at -80°C 
  • Room temperature: Suitable for short-term shipping within continental US 

Multiple freeze-thaw cycles should be avoided. Once prepared, aliquot and store the solution to prevent product inactivation .


📞 Need Help Choosing Your S-23 Format?

Whether you require capsules, liquid, or bulk powder, our team can assist with questions about purity verification, storage protocols, and next-day delivery across the UK.

Contact Support


Dosing Considerations for Laboratory Research

S-23 exhibits an estimated half-life of approximately 11-12 hours based on rat pharmacokinetic studies, though human data is not formally characterized. For research applications, twice-daily dosing is recommended to maintain stable exposure levels.

Research Protocol Parameters

ParameterRecommendation
Typical Dose Range10-30 mg/day
Dosing FrequencySplit AM/PM due to ~12-hour half-life
Cycle Length6-10 weeks
Bioavailability96% (estimated from research models)
Time to Peak~2 hours post-administration

Researchers should note that S-23 induces near-complete suppression of testosterone, LH, and FSH in animal models. This profile makes S-23 a high-risk compound for research applications involving reproductive endocrinology studies.

Purity and Quality Verification

For researchers seeking an hplc tested sr9009 uk vendor (or S-23 specifically), quality documentation is essential. The minimum purity standard for research-grade S-23 is ≥98%, with some suppliers achieving ≥99.93% purity .

What a Legitimate COA Must Include

  • HPLC purity analysis with chromatogram confirming ≥98% purity
  • Mass spectrometry data confirming molecular weight (416.75 g/mol)
  • Batch-specific traceability—not generic templates
  • Third-party laboratory accreditation (e.g., MZ Biolabs) 
  • Storage and retest date information

In-house product testing is considered biased because the company’s scientists conduct the analysis. A COA should only be trusted if produced by a third party.

UK Regulatory Context

S-23 is supplied strictly for laboratory and educational research purposes. It is not approved for human consumption, therapeutic use, cosmetic application, or veterinary purposes.

Compliance Requirements

  • Products should be used exclusively in controlled research environments
  • Institutional laboratory safety protocols and ethical research guidelines must be followed
  • UK suppliers typically require orders to be dispatched to scientific business or laboratory addresses
  • Products are classified as research chemicals and are not subject to medicinal regulation

Common Buyer Scenarios

The Protocol-Specific Researcher: You require pre-measured doses for standardised research. Capsule/tablet formats offer convenience and consistency with third-party purity verification.

The Flexible Researcher: You need to adjust dosing volumes for varied protocols. Liquid formulations provide greater control and fewer excipients.

The Long-Term Study: You require compound stability over extended timelines. Powder at -20°C provides 3-year stability; solutions should be used within 1 year at -20°C .

The Quality-Focused Laboratory: You require batch-specific COA verification with independent HPLC testing. Look for suppliers who provide third-party analytical documentation.

Conclusion

The choice between S-23 liquid and capsule formats depends on your specific research requirements, handling preferences, and storage capabilities. Capsules offer pre-measured convenience with proven third-party purity verification (≥98%), while liquid formulations provide flexible dosing with fewer excipients. Both formats are available from UK suppliers, with next-day delivery options for research hubs including London, Manchester, Birmingham, Glasgow, and Leeds. Always prioritize suppliers who can provide batch-specific, third-party COA verification with HPLC purity data and clear storage instructions.

One comment

Leave a Reply

Your email address will not be published. Required fields are marked *